We would appreciate it if you could provide the latest evidence for the mass-production release, including the status of trial acceptance, capability, and unresolved risks, by 3 p.m. today.

PCBA Engineering & NPIMass Production ReleaseB2formal

รบกวนช่วยส่ง Evidence ล่าสุดของการ Release Mass Production รวมถึงสถานะเรื่อง ผล Trial, Capability และความเสี่ยงที่ยังเปิดอยู่ ภายในบ่าย 3 โมงวันนี้

แกะรูปประโยค

สถานการณ์ / Intent

Formal email request

Grammar / Pattern

would appreciate + could

คำศัพท์สำคัญ

mass-production release; trial acceptance, capability, and unresolved risks

ระดับภาษา

B2 · formal

ใช้ประโยคนี้อย่างไร

ใช้รูป We would appreciate it if you could... เมื่อขอความร่วมมือแบบเป็นทางการ และระบุ Deliverable + Deadline ให้ครบ

พูด/เขียนได้หลายแบบ

CASUAL

Can we check the mass-production release and close the remaining points on trial acceptance, capability, and unresolved risks?

ALTERNATIVE

For the mass-production release, confirm the latest revision, the cut-in point, validation evidence, and any open risk before release.

Grammar Reference

We would appreciate it if…We would appreciate it if… สำหรับคำขอแบบเป็นทางการ · We would appreciate it if + subject + could + base verb Could you please…?Could you please…? สำหรับการขออย่างสุภาพ · Could you please + base verb + ...?Indirect Questions for Professional CommunicationIndirect Question สำหรับถามแบบมืออาชีพ · Could you confirm / Do you know + question clause

แกะรูปประโยค

ใช้ประโยคนี้อย่างไร

พูด/เขียนได้หลายแบบ

Grammar Reference

ประโยคใกล้เคียง

Do not release the mass-production release until the latest revision, cut-in point, validation evidence, and open risks have been reviewed with the responsible functions.

Before the next release, verify the controls for trial acceptance, capability, and unresolved risks in the mass-production release.

The team is reviewing the controls for trial acceptance, capability, and unresolved risks as part of the mass-production release.

We found a gap in the mass-production release: one or more controls related to trial acceptance, capability, and unresolved risks do not match the approved requirement.

If the mass-production release is not closed before the next build, the unresolved points around trial acceptance, capability, and unresolved risks may create a production or quality risk.

We have completed the initial review of the mass-production release and assigned owners for the remaining actions related to trial acceptance, capability, and unresolved risks.

Could you clarify how the controls for trial acceptance, capability, and unresolved risks will be verified and who will approve the mass-production release?

For management review, the main open point in the mass-production release is the control of trial acceptance, capability, and unresolved risks; the immediate risk is contained, and the team is working toward final closure.